⌘K

G1 Therapeutics, Inc. (GTHX)

$7.15 0.00% $0.00 Healthcare

G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/etoposide-containing regimen or topotecan-containing regimen for extensive stage small cell lung cancer. It is also developing trilaciclib, a (CDK) 4/6 inhibitor that is in Phase III clinical trials for patients with first line colorectal cancer; Phase III clinical trial for the treatment of first line triple negative breast cancer; Phase II clinical trial for patients with first line bladder cancer; Phase II clinical trial for patients with combination with the antibody-drug conjugate; and Phase II clinical trial for the treatment of neoadjuvant breast cancer. In addition, the company develops lerociclib, an oral CDK4/6 inhibitor for multiple oncology indications; and rintodestrant, an oral selective estrogen receptor degrader, which is in Phase IIa clinical trials for the treatment of estrogen receptor-positive and HER2-negative breast cancer. The company has a license agreement with EQRx, Inc. and Genor Biopharma Co. Inc. for the development and commercialization of lerociclib using an oral dosage form to treat any indication in humans, as well as Nanjing Simcere Dongyuan Pharmaceutical Co., LTD. for the development and commercialization of trilaciclib for any indication in humans through parenteral delivery, and ARC Therapeutics for the development and commercialization of a CDK2 inhibitor for all human and veterinary uses. G1 Therapeutics, Inc. was incorporated in 2008 and is headquartered in Research Triangle Park, North Carolina.

Market cap

$377.22M

CEO

Mr. John E. Bailey Jr.

Full time employees

148.00

Headquarters

Research Triangle Park, NC

IPO Date

May 17, 2017

Price-to-earnings (PE) Ratio

-8.31

Earnings-per-share (EPS)

$-0.86

Cash ratio (TTM)

0.40

Current ratio (TTM)

2.48

Net profit margin (TTM)

-76.93%

PE ratio (TTM)

-8.38

PEG ratio (TTM)

-0.36

Price-to-book ratio (TTM)

15.26

Price-to-sales ratio (TTM)

6.48

Quick ratio (TTM)

2.12

Return on assets (TTM)

-45.36%

Return on equity (TTM)

26.28%

Similar stocks (22)

Blueprint Medicines Corporation

BPMC

$91.99 1.15% $1.05

Downtrend

Axsome Therapeutics, Inc.

AXSM

$95.59 1.35% $1.27

Uptrend

Arcus Biosciences, Inc.

RCUS

$16.70 -0.60% $-0.10

Downtrend

Day One Biopharmaceuticals, Inc.

DAWN

$14.72 2.83% $0.40

Downtrend

Sana Biotechnology, Inc.

SANA

$4.31 -6.71% $-0.31

Downtrend

Annexon, Inc.

ANNX

$7.19 2.35% $0.16

Uptrend

Allogene Therapeutics, Inc.

ALLO

$2.90 -0.17% $-0.00

Downtrend

Larimar Therapeutics, Inc.

LRMR

$7.04 -1.40% $-0.10

Downtrend

Fate Therapeutics, Inc.

FATE

$3.88 -2.88% $-0.12

Downtrend

Heron Therapeutics, Inc.

HRTX

$2.00 -0.74% $-0.02

Downtrend

Amylyx Pharmaceuticals, Inc.

AMLX

$3.23 12.15% $0.35

Downtrend

MacroGenics, Inc.

MGNX

$3.31 -2.36% $-0.08

Downtrend

Caribou Biosciences, Inc.

CRBU

$2.08 0.70% $0.01

Downtrend

Sangamo Therapeutics, Inc.

SGMO

$0.88 -2.41% $-0.02

Uptrend

HOOKIPA Pharma Inc.

HOOK

$4.68 -0.85% $-0.04

Downtrend

Acumen Pharmaceuticals, Inc.

ABOS

$2.54 -1.55% $-0.04

Downtrend

Puma Biotechnology, Inc.

PBYI

$2.58 0.78% $0.02

Downtrend

Coherus BioSciences, Inc.

CHRS

$1.06 -5.77% $-0.06

Downtrend

X4 Pharmaceuticals, Inc.

XFOR

$0.70 -1.05% $-0.00

Downtrend

PDS Biotechnology Corporation

PDSB

$3.20 -0.31% $-0.01

Downtrend

Atara Biotherapeutics, Inc.

ATRA

$7.87 -0.76% $-0.06

Downtrend

Galera Therapeutics, Inc.

GRTX

$0.08 0.00% $0.00

Downtrend

ETF Exposure (21)

Invesco NASDAQ Future Gen 200 ETF

QQQS

1.12%

$27.63 0.44% $0.12

Uptrend

iShares Micro-Cap ETF

IWC

0.09407%

$125.35 -0.94% $-1.19

Uptrend

iShares Russell 2000 Growth ETF

IWO

0.02747%

$284.77 -0.35% $-1.00

Uptrend

Vanguard Russell 2000 Growth Index Fund

VTWG

0.02%

$207.60 -0.34% $-0.70

Uptrend

iShares Russell 2000 ETF

IWM

0.01393%

$222.14 -0.82% $-1.83

Uptrend

Vanguard Russell 2000 Index Fund

VTWO

0.01%

$89.88 -0.77% $-0.70

Uptrend

ProShares Ultra Russell2000

UWM

0.005211215873673953%

$43.36 -1.64% $-0.72

Uptrend

ProShares UltraPro Russell2000

URTY

0.0025694862692013536%

$52.89 -2.54% $-1.38

Uptrend

ProShares Hedge Replication ETF

HDG

0.002175913319914154%

$50.11 0.08% $0.04

Uptrend

Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF

GSSC

$69.62 -0.85% $-0.60

Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

$49.96 1.07% $0.53

Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

$49.95 1.07% $0.53

Uptrend

Vanguard Balanced Index Fund

VBINX

$49.94 1.05% $0.52

Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$138.77 2.02% $2.75

Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

$97.80 1.74% $1.67

Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

$97.78 1.74% $1.67

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$137.33 1.73% $2.34

Uptrend

Vanguard Russell 3000 Index Fund

VTHR

$251.87 -0.47% $-1.19

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$281.23 -0.29% $-0.82

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$137.30 1.73% $2.33

Uptrend

Vanguard Extended Market Index Fund

VXF

$181.72 -0.66% $-1.20

Uptrend

Similar stocks (22)

Blueprint Medicines Corporation

BPMC

$91.99 1.15% $1.05

Downtrend

Axsome Therapeutics, Inc.

AXSM

$95.59 1.35% $1.27

Uptrend

Arcus Biosciences, Inc.

RCUS

$16.70 -0.60% $-0.10

Downtrend

Day One Biopharmaceuticals, Inc.

DAWN

$14.72 2.83% $0.40

Downtrend

Sana Biotechnology, Inc.

SANA

$4.31 -6.71% $-0.31

Downtrend

Annexon, Inc.

ANNX

$7.19 2.35% $0.16

Uptrend

Allogene Therapeutics, Inc.

ALLO

$2.90 -0.17% $-0.00

Downtrend

Larimar Therapeutics, Inc.

LRMR

$7.04 -1.40% $-0.10

Downtrend

Fate Therapeutics, Inc.

FATE

$3.88 -2.88% $-0.12

Downtrend

Heron Therapeutics, Inc.

HRTX

$2.00 -0.74% $-0.02

Downtrend

Amylyx Pharmaceuticals, Inc.

AMLX

$3.23 12.15% $0.35

Downtrend

MacroGenics, Inc.

MGNX

$3.31 -2.36% $-0.08

Downtrend

Caribou Biosciences, Inc.

CRBU

$2.08 0.70% $0.01

Downtrend

Sangamo Therapeutics, Inc.

SGMO

$0.88 -2.41% $-0.02

Uptrend

HOOKIPA Pharma Inc.

HOOK

$4.68 -0.85% $-0.04

Downtrend

Acumen Pharmaceuticals, Inc.

ABOS

$2.54 -1.55% $-0.04

Downtrend

Puma Biotechnology, Inc.

PBYI

$2.58 0.78% $0.02

Downtrend

Coherus BioSciences, Inc.

CHRS

$1.06 -5.77% $-0.06

Downtrend

X4 Pharmaceuticals, Inc.

XFOR

$0.70 -1.05% $-0.00

Downtrend

PDS Biotechnology Corporation

PDSB

$3.20 -0.31% $-0.01

Downtrend

Atara Biotherapeutics, Inc.

ATRA

$7.87 -0.76% $-0.06

Downtrend

Galera Therapeutics, Inc.

GRTX

$0.08 0.00% $0.00

Downtrend

ETF Exposure (21)

Invesco NASDAQ Future Gen 200 ETF

QQQS

1.12%

$27.63 0.44% $0.12

Uptrend

iShares Micro-Cap ETF

IWC

0.09407%

$125.35 -0.94% $-1.19

Uptrend

iShares Russell 2000 Growth ETF

IWO

0.02747%

$284.77 -0.35% $-1.00

Uptrend

Vanguard Russell 2000 Growth Index Fund

VTWG

0.02%

$207.60 -0.34% $-0.70

Uptrend

iShares Russell 2000 ETF

IWM

0.01393%

$222.14 -0.82% $-1.83

Uptrend

Vanguard Russell 2000 Index Fund

VTWO

0.01%

$89.88 -0.77% $-0.70

Uptrend

ProShares Ultra Russell2000

UWM

0.005211215873673953%

$43.36 -1.64% $-0.72

Uptrend

ProShares UltraPro Russell2000

URTY

0.0025694862692013536%

$52.89 -2.54% $-1.38

Uptrend

ProShares Hedge Replication ETF

HDG

0.002175913319914154%

$50.11 0.08% $0.04

Uptrend

Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF

GSSC

$69.62 -0.85% $-0.60

Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

$49.96 1.07% $0.53

Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

$49.95 1.07% $0.53

Uptrend

Vanguard Balanced Index Fund

VBINX

$49.94 1.05% $0.52

Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$138.77 2.02% $2.75

Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

$97.80 1.74% $1.67

Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

$97.78 1.74% $1.67

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$137.33 1.73% $2.34

Uptrend

Vanguard Russell 3000 Index Fund

VTHR

$251.87 -0.47% $-1.19

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$281.23 -0.29% $-0.82

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$137.30 1.73% $2.33

Uptrend

Vanguard Extended Market Index Fund

VXF

$181.72 -0.66% $-1.20

Uptrend